Who
Veronica Sanchez Bulis
VP, Corporate Controller
Company insider
Files Form 4 as: VP, Corporate Controller, Lyell Immunopharma.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $190K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Nov 2025
- Last trade
- 10 Aug 2026
- Last filed
- 11 Aug 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 11 Aug 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $8,905621 at $14.34 | filing |
| 10 Aug 2026filed 11 Aug 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $8,905621 at $14.34 | filing |
| 11 May 2026filed 15 Jun 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $4,103217 at $18.91 | filing |
| 11 May 2026filed 15 Jun 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $4,103217 at $18.91 | filing |
| 10 Feb 2026filed 11 Feb 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Code A | —8,750 at $0.00 | filing |
| 10 Feb 2026filed 11 Feb 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $5,872254 at $23.12 | filing |
| 10 Feb 2026filed 11 Feb 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Code A | —8,750 at $0.00 | filing |
| 10 Feb 2026filed 11 Feb 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $5,872254 at $23.12 | filing |
| 30 Dec 2025filed 6 Jan 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $30K936 at $32.32 | filing |
| 30 Dec 2025filed 6 Jan 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $30K936 at $32.32 | filing |
| 24 Dec 2025filed 6 Jan 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $44K1,136 at $38.67 | filing |
| 24 Dec 2025filed 6 Jan 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $44K1,136 at $38.67 | filing |
| 10 Nov 2025filed 12 Nov 2025 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $3,848239 at $16.10 | filing |
News
Lyell Immunopharma (NASDAQ:LYEL) versus Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Critical ComparisonLYEL · themarketsdaily.com · 20 Oct 2026Reviewing Neuphoria Therapeutics (NASDAQ:NEUP) & Lyell Immunopharma (NASDAQ:LYEL)LYEL · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Veronica Sanchez Bulis; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.